Autopsy report · NCT01608776

RESPOND Restoring Equilibrium and Wound Stimulation to Promote Healing Of Non-healing DFUs

“Enrollment delays, business re-allocation of resources”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 10 months before it stopped.
• 13 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 4

Sponsor

Celleration, Inc.

Sponsor type

Industry

Conditions

Diabetic Foot Ulcer

Interventions

MIST Therapy; SOC - Standard of Care

Participants

13

Sites

1

Countries

United States

Trials that died the same way

• Hormonal Therapy and Chemotherapy Followed by Prostatectomy in Patients With Prostate Cancer
  “slow enrollment; resource re-allocation” (84% match in meaning)
• Convection-enhanced Delivery of OS2966 for Patients With High-grade Glioma Undergoing a Surgical Resection
  “Slow enrollment and financial constraints.” (71% match in meaning)
• Photon/Proton Radiation Therapy for Oropharyngeal Cancers
  “Slow enrollment, feasibility issues” (70% match in meaning)
• Safety Study of hMaxi-K Gene Transfer to Treat Overactive Bladder and Detrusor Overactivity
  “Slow enrollment and financial issues” (70% match in meaning)
• A Study of Dalteparin Prophylaxis in High-Risk Ambulatory Cancer Patients
  “slow enrollment and lack of continuing funds” (70% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.